MedTrace Logo

Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome

NCT00788229 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2010-04-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether artificial tears are safe and effective in the treatment of Dry Eye Syndrome.

Conditions

  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca

Interventions

DRUG

AT01

eye drop for 12 weeks

DRUG

AT02

eye drop for 12 weeks

DRUG

AT03

eye drop for 12 weeks

DRUG

AT04

eye drop for 12 weeks

Sponsors & Collaborators

  • Dhp Korea Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Hungwon Tchah,, MD · Seoul asan medical center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00788229 on ClinicalTrials.gov